Skip to main content
. 2018 Apr 25;2018(4):CD011689. doi: 10.1002/14651858.CD011689.pub2

Figure 73.

Figure 73

Cumulative rankograms comparing each of the uterotonic drugs for prevention of PPH ≥ 500 mL restricted to studies with funding source at low risk of bias (public or no funding).